A particular focus point is HDAC (Histone deacetylase) inhibition, classically utilized in cancer treatment, which has recently shown a neuroprotective capacity in many diseases, including IRD (Inherited retinal disease) [49]. The gene discussed is HDAC9; the disease is cancer.